Trial Outcomes & Findings for Monitoring Blood Pressure at Home (NCT NCT06247111)
NCT ID: NCT06247111
Last Updated: 2026-04-29
Results Overview
Number of participants enrolled into the study after screening and eligibility confirmation.
Recruitment status
ACTIVE_NOT_RECRUITING
Study phase
NA
Target enrollment
24 participants
Primary outcome timeframe
2 years
Results posted on
2026-04-29
Participant Flow
27 participants were screened and 24 were eligible and were enrolled.
24 participants who were eligible were enrolled.
Participant milestones
| Measure |
Usual Care
12 participants were randomized to usual care arm.
|
Intervention
12 participants were randomized to remote blood pressure monitoring
|
|---|---|---|
|
Overall Study
STARTED
|
12
|
12
|
|
Overall Study
COMPLETED
|
8
|
8
|
|
Overall Study
NOT COMPLETED
|
4
|
4
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Sex of participants
Baseline characteristics by cohort
| Measure |
Usual Care
n=12 Participants
12 participants were randomized to usual care arm.
|
Intervention
n=12 Participants
12 participants were randomized to remote blood pressure monitoring and pharamcist led Telehealth monitoring
|
Total
n=24 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
48.2 years
STANDARD_DEVIATION 13.6 • n=9 Participants
|
48.6 years
STANDARD_DEVIATION 12.5 • n=24 Participants
|
48.4 years
STANDARD_DEVIATION 12.8 • n=23 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=9 Participants • Sex of participants
|
6 Participants
n=24 Participants • Sex of participants
|
9 Participants
n=23 Participants • Sex of participants
|
|
Sex: Female, Male
Male
|
9 Participants
n=9 Participants • Sex of participants
|
6 Participants
n=24 Participants • Sex of participants
|
15 Participants
n=23 Participants • Sex of participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=9 Participants
|
0 Participants
n=24 Participants
|
0 Participants
n=23 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=9 Participants
|
0 Participants
n=24 Participants
|
0 Participants
n=23 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=9 Participants
|
0 Participants
n=24 Participants
|
0 Participants
n=23 Participants
|
|
Race (NIH/OMB)
Black or African American
|
8 Participants
n=9 Participants
|
9 Participants
n=24 Participants
|
17 Participants
n=23 Participants
|
|
Race (NIH/OMB)
White
|
3 Participants
n=9 Participants
|
2 Participants
n=24 Participants
|
5 Participants
n=23 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=9 Participants
|
0 Participants
n=24 Participants
|
0 Participants
n=23 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=9 Participants
|
1 Participants
n=24 Participants
|
2 Participants
n=23 Participants
|
PRIMARY outcome
Timeframe: 2 yearsPopulation: Overall Number of Participants Analyzed represents the number of participants screened for study interest prior to enrollment. Of 27 screened, 24 were eligible and successfully enrolled.
Number of participants enrolled into the study after screening and eligibility confirmation.
Outcome measures
| Measure |
All Participants
n=27 Participants
All participants screened for study interest and eligibility prior to enrollment
|
Remote Blood Pressure Monitoring + Telehealth
Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
|
|---|---|---|
|
Total Number of Recruited Participants
|
24 Participants
|
—
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 3 months from randomizationNumber of participants who completed the final study visit conducted approximately three months after randomization.
Outcome measures
| Measure |
All Participants
n=12 Participants
All participants screened for study interest and eligibility prior to enrollment
|
Remote Blood Pressure Monitoring + Telehealth
n=12 Participants
Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management
|
|---|---|---|
|
Number of Participants Who Attended Last Study Visit
|
8 number of participants
|
8 number of participants
|
Adverse Events
Usual Care
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Remote Blood Pressure Monitoring + Telehealth
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place